<DOC>
	<DOCNO>NCT02934893</DOCNO>
	<brief_summary>The benefit drug therapy person diabetes well establish clinical trial term reduce cardiovascular risk , microvascular complication mortality . However , treatment adherence treatment effectiveness continue challenge diabetes management . Rimidi Diabetes develop software algorithm simulate effect anti-diabetic medication individual 's glucose profile , allow clinician patient visualize anticipate outcome medical intervention . Use technology allow target decision-making clinician facilitate share decision-making process PwD privy think process behind medical management . The propose study design test whether add decision support capability ( Diabetes+Me Rx ) allow model anticipated effect medication adjustment lead improved glycemic control perceive benefit healthcare provider PwDs .</brief_summary>
	<brief_title>A Study Evaluate Effect Benefit Diabetes Management Decision Support Software Blood Glucose Control</brief_title>
	<detailed_description>- Recruitment - Recruitment person diabetes community diabetes management center accord inclusion exclusion criterion . - This three-armed study . Enrollees randomize continue diabetes care standard diabetes management Medication Management Clinic Intervention Group compare match cohort manage primary care physician ( PCP ) standard care . - The Intervention Group standard diabetes management Medication Management Clinic plus use Diabetes+Me connected glucometer . - Upon recruitment , PwD orient Diabetes+Me application instruct complete glucose profile enter data application . Baseline hemoglobin A1C measure . - Enrollees complete brief survey satisfaction diabetes management . - Study visit - The first study visit 2 week follow enrollment . - Weight , number medication , number medication titration , presence insulin blood pressure measure study visit . Frequency hypoglycemia precede week document visit . Adherence medical prescription document visit . - If PwD enter data Diabetes+Me do begin study visit . - At first study visit , HCP review glucose profile previous week , identify area PwD meet target model adjustment medication achieve desire anticipated effect . If indicate , new prescription issue PwD instruct collect new glucose profile week precede next visit . - The second study visit occur 5 week follow initial visit . The HCP PwD review glucose profile previous week , identify area PwD meet target model adjustment medication achieve desire anticipated effect . If indicate , new prescription issue PwD instruct collect new glucose profile week precede final visit . The third final study visit occur 5 week follow second visit . The HCP PwD review glucose profile previous week identify PwD meet target .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Physician diagnosis type 1 type 2 diabetes Glycated hemoglobin &gt; 9 % within 3 month Age 1880 Not currently manage study clinician Pregnant Active substance abuse Severe hear visual impairment No internet email access</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>